Keurig Dr Pepper Named Among Top Value Stocks with High Dividends
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 28 2026
0mins
Should l Buy KDP?
Source: Yahoo Finance
- Price Target Increase: Barclays raised its price target for Keurig Dr Pepper from $30 to $32, indicating market confidence in the company's future performance while maintaining an Equal Weight rating, reflecting recognition of stable growth prospects.
- Strong Performance: CEO Timothy Cofer highlighted that 2025 was a strong year for the company, meeting full-year guidance, with innovation and strong commercial execution being key drivers of retail sales growth, showcasing the company's competitive edge in a challenging market.
- Market Share Growth: Keurig Dr Pepper achieved the fastest retail sales growth among major food and beverage manufacturers while gaining market share across its portfolio, indicating increased product popularity and enhanced market competitiveness.
- Strategic Restructuring Plans: The company plans to separate into Beverage Co and Global Coffee Co while completing the acquisition of JDE Peet's, aiming to establish two well-positioned, independent businesses to strengthen long-term competitiveness and market adaptability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KDP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KDP
Wall Street analysts forecast KDP stock price to rise
12 Analyst Rating
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 28.190
Low
26.00
Averages
34.58
High
42.00
Current: 28.190
Low
26.00
Averages
34.58
High
42.00
About KDP
Keurig Dr Pepper Inc. is a beverage company in North America that manufactures, markets, distributes and sells hot and cold beverages and single serve brewing systems. It has a portfolio of beverage brands, including Keurig, Dr Pepper, Canada Dry, Mott's, A&W, Penafiel, Snapple, 7UP, Green Mountain Coffee Roasters, GHOST, Clamato, Core Hydration and The Original Donut Shop, as well as the Keurig brewing system. Its U.S. Refreshment Beverages segment is a manufacturer and distributor of liquid refreshment beverages (LRBs). This segment manufactures and distributes concentrates, syrup and finished beverages of its brands and third-party brands, to third-party bottlers, distributors, retailers, and end consumers. Its U.S. Coffee segment is a manufacturer and distributor of single serve brewers, specialty coffee (including hot and iced varieties), and ready to drink (RTD) coffee. Its International segment includes sales in Canada, Mexico, the Caribbean and other international markets.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Keurig Dr Pepper's Financial Strategy: The company plans to utilize borrowings to fund its acquisition of JDE Peet's, indicating a strategic move to enhance its market position.
Acquisition Details: The acquisition of JDE Peet's is part of Keurig Dr Pepper's broader strategy to expand its portfolio and strengthen its presence in the beverage industry.
See More

Keurig Dr Pepper Update: The company is set to be released from a term loan agreement following a separation process.
Maple Acquisition: Maple is positioned to become the sole borrower in this financial restructuring.
See More

- Loan Extension: Keurig Dr Pepper has extended the maturity of its EUR 2.6 billion term loan to 15 months from the initial funding date.
- Financial Strategy: This move is part of the company's strategy to manage its financial obligations and improve liquidity.
See More
- Investor Pressure: There is increasing pressure from investors in the packaged-food and restaurant sectors due to slow sales growth.
- Shifting Consumer Habits: Changing consumer preferences are prompting activists to seek ways to unlock value in these industries.
See More
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More








